# The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients

> **NCT01343862** · PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 100 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** D-cycloserine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01343862
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01343862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01343862, "The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01343862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*